Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema.
Br J Ophthalmol
; 107(1): 79-83, 2023 01.
Article
in En
| MEDLINE
| ID: mdl-34340975
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Cataract
/
Macular Edema
/
Diabetes Mellitus
/
Diabetic Retinopathy
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Br J Ophthalmol
Year:
2023
Document type:
Article
Affiliation country:
Australia
Country of publication:
Reino Unido